Format

Send to

Choose Destination
Dermatol Ther. 2020 Jan 24:e13230. doi: 10.1111/dth.13230. [Epub ahead of print]

Refractory palmoplantar pustulosis succesfully treated with apremilast.

Author information

1
Dermatology Department, Hospital Universitario Infanta Leonor, Madrid, Spain.

Abstract

Palmoplantar pustulosis is a chronic inflammatory disease which characterized by a eruption of sterile pustules on the palms and soles. Apremilast is an oral phosphodiesterase-4 inhibitor which is approved for the treatment of chronic plaque psoriasis and psoriatic arthritis. However, no clinical trial has been performed to confirm the efficacy of apremilast for palmoplantar pustulosis yet. Moreover, there are very few cases of this disease treated with apremilast. Herein, we describe a case of a refractory palmoplantar pustulosis succesfully treated with apremilast.

KEYWORDS:

inflammatory disorders; psoriasis; therapy-systemic

PMID:
31981290
DOI:
10.1111/dth.13230

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center